TLDR
- Canopy Growth reported C$298.1M in cash and cash equivalents for Q2, exceeding debt by C$70M and resolving going concern doubts that previously worried investors.
- The company posted a net loss of C$1.6M but beat earnings estimates by C$0.17 per share, though revenue of C$66.7M missed expectations by C$5.1M.
- Canadian adult-use cannabis sales surged 30% year-over-year to C$23.9M, driving overall cannabis segment revenue up 12% to C$50.8M.
- International cannabis markets contracted 39% year-over-year while the Storz & Bickel accessories segment declined 10% to C$15.8M in revenue.
- Operating losses dropped 63% year-over-year to C$16.8M as the company reduced selling, general and administrative expenses by 13% through operational efficiencies.
Canopy Growth shares jumped 19% in premarket trading Friday following second quarter earnings results that addressed investor worries about the company’s financial stability. The Canadian cannabis producer reported numbers that showed both progress and challenges in its business operations.
Canopy Growth Corporation, CGC
The company ended September 30 with C$298.1M in cash and cash equivalents. This amount exceeded its total debt by C$70M. The improved financial position allowed Canopy Growth to officially resolve conditions that had raised substantial doubt about its ability to continue as a going concern.
The earnings report showed a net loss of C$1.6M for the quarter. This result beat analyst estimates by C$0.17 per share. Revenue came in at C$66.7M, missing consensus expectations by C$5.1M despite posting 6% growth compared to the same period last year.
The revenue growth came primarily from the company’s Canadian operations. The cannabis segment generated C$50.8M in revenue, up 12% from the previous year. Canadian adult-use cannabis sales led this growth with C$23.9M in revenue, climbing 30% year-over-year.
International cannabis sales told a different story. These markets saw revenue drop 39% compared to the prior year. The company did not provide specific reasons for this decline in the international segment.
Mixed Performance Across Business Segments
The Storz & Bickel accessories division brought in C$15.8M in net revenue. This represented a 10% decrease from the same quarter last year. Canopy Growth attributed the drop to strong sales in the prior year period and current consumer economic uncertainty.
Gross margin slipped 200 basis points to 33% for the quarter. The company said lower cannabis gross margins drove this decline. However, selling, general and administrative expenses fell 13% year-over-year thanks to operational efficiencies.
These cost reductions helped cut the operating loss by 63% to C$16.8M. CEO Luc Mongeau stated the company is building a stronger and more competitive business. He pointed to continued momentum in Canadian adult-use cannabis and consistent growth in Canadian medical cannabis.
Financial Metrics Show Room for Improvement
The company’s balance sheet shows a current ratio of 3.07, indicating reasonable liquidity levels. The debt-to-equity ratio stands at 0.67, reflecting the debt burden the company carries. The Altman Z-Score of -17.31 puts Canopy Growth in the distress zone.
Revenue has declined 41% over the past three years. Operating margin sits at negative 22.89% while net margin comes in at negative 186.42%. The gross margin of 27.11% shows the company still faces profitability challenges.
The stock trades at a price-to-sales ratio of 0.73 and a price-to-book ratio of 0.67. Analysts maintain a hold recommendation on the shares. The RSI indicator of 34.41 suggests the stock is approaching oversold territory.
Institutional ownership stands at 5.63% while insiders own 3.66% of shares. The stock shows high volatility at 117.6 and a beta of negative 0.48, meaning it tends to move opposite to the broader market.
Canopy Growth’s cash position now exceeds its debt by C$70M, with C$298.1M in cash and cash equivalents as of September 30.


